Business · 1 sources covering this

Glenmark Pharma Q2 revenue falls 30% to ₹4,247 crore, profit down 57%

Glenmark Pharmaceuticals' Q2FY27 net profit fell 56.8% to ₹263.83 crore, while revenue declined 29.8% to ₹4,247.32 crore, with earnings dragged by exceptional items.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
Glenmark Pharma Q2 revenue falls 30% to ₹4,247 crore, profit down 57%
Glenmark Pharmaceuticals' Q2FY27 net profit fell 56.8% to ₹263.83 crore, while revenue declined 29.8% to ₹4,247.32 crore, with earnings dragged by exceptional items.
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/5b9b5613f20afa101bf1767ea76f4786c474a0f1"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Glenmark Pharma Q2 revenue falls 30% to ₹4,247 crore, profit down 57%"></iframe>

Glenmark Pharma Q2 revenue falls 30% to ₹4,247 crore, profit down 57%

How 1 sources are covering this

Glenmark Pharma Q2 revenue falls 30% to ₹4,247 crore, profit down 57%

More from Business

India plans visa overhaul, cut categories from 13 to nine and simplify application forms — What will change

Signature Global Q2 net profit at ₹70 crore as revenue rises 148%

Govt panel proposes sale of MTNL assets worth ₹1,100 crore to cut debt

Renewable energy investments may exceed $220 bn by 2030: Pralhad Joshi

Reader

Trust & legal

Across the network